Detection of myocardial injury after internal cardioversion for atrial fibrillation

Canadian Journal of Cardiology

Volumn 20, Issue 2, 2004, Pages 165-168

  Gorenek, Bulent ^a,b   Kudaiberdieva, G ^a   Goktekin, O ^a   Cavusoglu, Y ^a   Birdane, A ^a   Ata, N ^a   Unalir, A ^a   Timuralp, B ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^b NONE   (Turkey)

Author keywords

Atrial fibrillation; Internal cardioversion; Myocardial injury

Indexed keywords

AMIODARONE; BIOLOGICAL MARKER; CREATINE KINASE MB; DIGITALIS; MYOGLOBIN; PROPAFENONE; SOTALOL; TROPONIN I; TROPONIN T;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS; CREATINE KINASE BLOOD LEVEL; DEFIBRILLATOR; DISEASE SEVERITY; ELECTRODE; FEMALE; FEMORAL VEIN; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART MUSCLE INJURY; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE; HEART VENTRICLE PACING; HUMAN; MALE; R WAVE; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CHRONIC DISEASE; CREATINE KINASE; CREATINE KINASE, MB FORM; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOGLOBIN; STATISTICS; STROKE VOLUME; TREATMENT OUTCOME; TROPONIN I; TROPONIN T;

EID: 1642445316     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Levy S, Lauribe P, Dolla A, et al. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 1992;86:1415-20.
2. Baker BM, Botteron GW, Smith JM. Low energy internal cardioversion for atrial fibrillation resistant to external cardioversion. J Cardiovasc Electrophysiol 1995;6:44-7.
3. Smith BM, Alt E, Plewan A, et al. Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J Am Coll Cardiol 1996;28:994-9.
4. Gronefeld GC, Li YG, Bogun F, Hohnloser SH. Efficacy and safety of transvenous atrial cardioversion in patients with mitral valve disease and long-standing atrial fibrillation. Pacing Clin Electrophysiol 2000;23:1894-7.
5. Gazmuri RJ. Effects of repetitive electrical shocks on postresuscitation myocardial function. Crit Care Med 2000;28(11 Suppl):N228-32.
6. Niemann JT, Burian D, Garner D, Lewis RJ. Transthoracic monophasic and biphasic defibrillation in a swine model: A comparison of efficacy, ST segment changes, and postshock hemodynamics. Resuscitation 2000;47:51-8.
7. Grubb NR, Fox KA, Cawood P. Resuscitation from out-of-hospital cardiac arrest: Implications for cardiac enzyme estimation. Resuscitation 1996;33:35-41.
8. Ricard P, Levy S, Boccara G, Lakhal E, Bardy G. External cardioversion of atrial fibrillation: Comparison of biphasic vs monophasic waveform shocks. Europace 2001;3:96-9.
9. Vikenes K, Omvik P, Farstad M, Nordrehaug JE. Cardiac biochemical markers after cardioversion of atrial fibrillation or atrial flutter. Am Heart J 2000;140:690-6.
10. Greaves K, Crake T. Cardiac troponin T does not increase after electrical cardioversion for atrial fibrillation or atrial flutter. Heart 1998;80:226-8.
11. Georges JL, Spentchian M, Caubel C, et al. Time course of troponin I, myoglobulin, and cardiac enzyme release after electrical cardioversion. Am J Cardiol 1996;78:825-6.
12. Antman EM, Grudzien C, Mitchell RN, Sacks DB. Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T. Am Heart J 1997;133:596-8.
13. Manolis AS, Vassilikos V, Maounis T, et al. Detection of myocardial injury during radiofrequency catheter ablation by measuring serum cardiac troponin I levels: Procedural correlates. J Am Coll Cardiol 1999:34;1099-105.
14. Schluter T, Baum H, Plewan A, Neumeier D. Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage. Clin Chem 2001;47:459-63.
15. Rao SP, Miller S, Rosenbaum R, Lakier JB. Cardiac troponin I and cardiac enzymes after electrophysiologic studies, ablations, and defibrillator implantations. Am J Cardiol 1999;84:470, A9.
16. Boriani G, Biffi M, Cervi V, et al. Evaluation of myocardial injury following repeated internal atrial shocks by monitoring serum cardiac troponin I levels. Chest 2000;118:342-7.
17. Muller-Bardorff M, Sylven C, Rasmanis G, et al. Evaluation of a point-of-care system for quantitative determination of troponin T and myoglobin. Clin Chem Lab Med 2000;38:567-74.
18. Lestin M, Hergert M, Lestin HG, et al. Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems. Clin Lab 2002;48:211-21.
19. Michael P, Hudson MD, Christopher B, et al. Early reinfarction after fibrinolysis: Experience from the Global Utilization of Streptokinase and Tissue Plasminogen Activator (Alteplase) for Occluded Coronary Arteries (GUSTO I) and Global Use of Strategies To Open Occluded Coronary Arteries (GUSTO III) trials. Circulation 2001;104:1229-35.
20. Myocardial infarction redefined - A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36.
21. Hurst TM, Hinrichs M, Breidenbach C, Katz N, Waldecker B. Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. J Am Coll Cardiol 1999;34:402-8.
22. Lund M, French JK, Johnson RN, Williams BF, White HD. Serum troponins T and I after elective cardioversion. Eur Heart J 2000;21:171-3.
23. Allan JJ, Feld RD, Russell AA, et al. Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion. J Am Coll Cardiol 1997;30:1052-6.